Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
ACORN CAPITAL ADVISORS, LLC (CIK 2054410) reported $351.8M across 22 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: TERN ($92.1M, 26.17%), CGON ($76.6M, 21.77%), URGN ($30.1M, 8.55%), PBYI ($26.4M, 7.50%), TRVI ($25.6M, 7.27%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | TERN | TERNS PHARMACEUTICALS INC | $92.1M | 26.17% | 1.7M | Hold |
| 2 | CGON | CG ONCOLOGY INC | $76.6M | 21.77% | 1.1M | Trimmed |
| 3 | URGN | UROGEN PHARMA LTD | $30.1M | 8.55% | 1.7M | Added |
| 4 | PBYI | PUMA BIOTECHNOLOGY INC | $26.4M | 7.50% | 4.1M | Hold |
| 5 | TRVI | TREVI THERAPEUTICS INC | $25.6M | 7.27% | 2.1M | Hold |
| 6 | CADL | CANDEL THERAPEUTICS INC | $17.2M | 4.89% | 3.5M | Added |
| 7 | BCAX | BICARA THERAPEUTICS | $12.8M | 3.64% | 643,382 | Hold |
| 8 | OKUR | ONKURE THERAPEUTICS INC | $11.8M | 3.34% | 2.8M | Hold |
| 9 | JBIO | JADE BIOSCEINCES INC | $11.1M | 3.14% | 786,760 | New |
| 10 | TARA | PROTARA THERAPEUTICS INC | $9.1M | 2.59% | 1.8M | Hold |
| 11 | VSTM | VERASTEM INC | $7.8M | 2.21% | 1.5M | Hold |
| 12 | CYBN | HELUS PHARMA INC. | $7.4M | 2.10% | 1.5M | Trimmed |
| 13 | ATHA | LEONABIO, INC. | $6.5M | 1.85% | 634,539 | Added |
| 14 | AURA | AURA BIOSCIENCES INC | $4.0M | 1.13% | 595,744 | Hold |
| 15 | WHWK | WHITEHAWK THERAPEUTICS INC | $3.9M | 1.12% | 1.1M | Hold |
| 16 | CRDF | CARDIF ONCOLOGY INC | $2.9M | 0.81% | 1.8M | Trimmed |
| 17 | QTTB | Q32 BIO INC. | $2.0M | 0.57% | 315,052 | Trimmed |
| 18 | KPTI | KARYOPHARM THERAPEUTICS INC | $1.6M | 0.46% | 287,826 | New |
| 19 | JSPR | JASPER THERAPEUTICS | $1.2M | 0.35% | 1.4M | Trimmed |
| 20 | XFOR | X4 PHARMACEUTICALS INC | $966,583 | 0.27% | 234,039 | Trimmed |
| 21 | BCAB | BIOATLA INC | $865,015 | 0.25% | 5.4M | Added |
| 22 | ACRV | ACRIVON THERAPEUTICS INC | $0 | 0.00% | 0 | Exited |
| 23 | VYNE | VYNE THERAPEUTICS INC | $855 | 0.00% | 1,425 | Hold |
Source: SEC Form 13F filings · as of 2026-03-31